Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Evelyn Lopez-Brignoni"'
Autor:
Lindsay H Burns, Tamara Doehner, John Puente, Brian Beck, Yaneicy Gonzalez‐Rojas, Evelyn Lopez‐Brignoni, Boris Nikolov, Hoau‐Yan Wang, Zhe Pei, Antonio Hernandez, Carrie A Crowley, Nadav Friedmann
Publikováno v:
Alzheimer's & Dementia. 17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61c849d873a19181f197589c4ae21435
https://doi.org/10.1002/alz.054395
https://doi.org/10.1002/alz.054395
Autor:
Brian Beck, Yaneicy Gonzalez Rojas, John Puente, Carrie A Crowley, Kuo-Chieh Lee, Evelyn Lopez-Brignoni, Tamara Doehner, Hoau-Yan Wang, Patrick Sciara, Boris Nikolov, Nadav Friedmann, Remi Barbier, Lindsay H. Burns, George Ben Thornton, Jeffrey L. Cummings, Zhe Pei
BACKGROUND Simufilam is a first-in-class drug candidate targeting altered filamin A, a proteopathy in Alzheimer’s disease. The primary objective of this Phase 2 clinical trial was to evaluate the effects of simufilam on cerebrospinal fluid (CSF) bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e1101c8f80628d9a2a703194cbbbadf
https://doi.org/10.21203/rs.3.rs-249858/v1
https://doi.org/10.21203/rs.3.rs-249858/v1
Autor:
N. Friedmann, Zhe Pei, Evelyn Lopez-Brignoni, Carrie A Crowley, Kuo-Chieh Lee, M. R. Marsman, Remi Barbier, Boris Nikolov, Hoau-Yan Wang, Lindsay H. Burns
Publikováno v:
The journal of prevention of Alzheimer's disease. 7(4)
BACKGROUND: The most common dementia worldwide, Alzheimer’s disease is often diagnosed via biomarkers in cerebrospinal fluid, including reduced levels of Aβ1–42, and increases in total tau and phosphorylated tau-181. Here we describe results of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7fa457568d82a68d03124d9c16abb01
https://pubmed.ncbi.nlm.nih.gov/32920628
https://pubmed.ncbi.nlm.nih.gov/32920628